Expanded 2-year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

OBJECTIVE: To report expanded 2-year follow up of a previously reported randomized trial evaluating intravitreal 0.5-mg ranibizumab or 4-mg triamcinolone combined with focal/grid laser compared with focal/grid laser alone for treatment of diabetic macular edema (DME). DESIGN: Multicenter, randomized...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elman, Michael J., Bressler, Neil M., Qin, Haijing, Beck, Roy W., Ferris, Frederick L., Friedman, Scott M., Glassman, Adam R., Scott, Ingrid U., Stockdale, Cynthia R., Sun, Jennifer K.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3096445/
https://ncbi.nlm.nih.gov/pubmed/21459214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2010.12.033
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires